IBA (Ion Beam Applications S.A.), a global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, is proud to support the Union for International Cancer Control (UICC) by participating in World Cancer Day on February 4, 2015. IBA’s mission to “Protect, Enhance and Save Lives” reflects the understanding that lives are impacted by the efforts of all of IBA’s employees in developing the solutions, education and services for fighting cancer. World Cancer Day offers the perfect platform to take a moment and focus on this cause from a very personal aspect.

A new Mayo Clinic study finds that not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all of their underarm nodes taken out. Ultrasound is a useful tool for judging before breast cancer surgery whether chemotherapy eliminated cancer from the underarm lymph nodes, the researchers found. The findings are published in the Journal of Clinical Oncology.

February 4, 2015 — Lantheus Medical Imaging Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...

Intelerad Medical Systems has been awarded a five-year, Schedule 70 contract with the U.S. General Services Administration (GSA).

Carestream Health was awarded 66 new patents from the U.S. Patent and Trademark Office in 2014 for innovations in radiology imaging, healthcare information technology (IT), dental imaging and other areas. The company also received 34 additional patents in European and Asian countries last year.

Hospitals and healthcare systems are facing unprecedented threats to their bottom lines, challenging them to curtail costs, increase revenue and improve the delivery of efficient quality patient care. In this tumultuous environment, MedQuest Radiology Management Services is seeing greater demand for its assessment services that help healthcare organizations identify areas for improvement within their radiology operations.

Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study published today in JAMA.

Time Magazine cast a spotlight on the dramatic impact of digital breast tomosynthesis (DBT) in detecting cancers (particularly in women with dense breasts) in its article entitled “11 Remarkable Health Advances from 2014.”